The risk of a form of heart inflammation is higher for people under 40 after receiving Moderna’s COVID-19 vaccine versus contracting COVID-19, according to a new study. Researchers found 15 excess cases per 1 million people who received a second dose of the vaccine compared to 10 extra cases of myocarditis following a positive COVID-19 test in the population. Moderna’s vaccine is typically taken in a two-dose regimen. The risk of myocarditis, a form of heart inflammation, was much higher following the second dose, but there were still eight excess cases per 1 million people following the first dose. “Time to abandon the belief that COVID-19 myocarditis risk is always higher than mRNA vaccine myocarditis risk. For some individuals, myocarditis risks of the vaccine(s) are higher than those of the disease,” Euzebiusz Jamrozik, an infectious disease expert who works at the University of Oxford, wrote on Twitter. The elevated risk …